AU749382B2 - Novel surface exposed proteins from chlamydia pneumoniae - Google Patents

Novel surface exposed proteins from chlamydia pneumoniae Download PDF

Info

Publication number
AU749382B2
AU749382B2 AU80119/98A AU8011998A AU749382B2 AU 749382 B2 AU749382 B2 AU 749382B2 AU 80119/98 A AU80119/98 A AU 80119/98A AU 8011998 A AU8011998 A AU 8011998A AU 749382 B2 AU749382 B2 AU 749382B2
Authority
AU
Australia
Prior art keywords
seq
ser
gly
thr
leu
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU80119/98A
Other languages
English (en)
Other versions
AU8011998A (en
Inventor
Svend Birkelund
Gunna Christiansen
Anna-Sofie Hebsgaard Pedersen
Katrine Knudsen
Per Mygind
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LOKE DIAGNOSTICS APS
Original Assignee
LOKE DIAGNOSTICS APS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LOKE DIAGNOSTICS APS filed Critical LOKE DIAGNOSTICS APS
Publication of AU8011998A publication Critical patent/AU8011998A/en
Assigned to LOKE DIAGNOSTICS APS reassignment LOKE DIAGNOSTICS APS Alteration of Name(s) of Applicant(s) under S113 Assignors: BIRKELUND, SVEND, CHRISTIANSEN, GUNNA
Application granted granted Critical
Publication of AU749382B2 publication Critical patent/AU749382B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/295—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Chlamydiales (O)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Gram-negative bacteria
    • C07K16/125—Gram-negative bacteria from Chlamydiales (O)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AU80119/98A 1997-06-23 1998-06-19 Novel surface exposed proteins from chlamydia pneumoniae Ceased AU749382B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DK74497 1997-06-23
DK0744/97 1997-06-23
PCT/DK1998/000266 WO1998058953A2 (en) 1997-06-23 1998-06-19 Surface exposed proteins from chlamydia pneumoniae

Publications (2)

Publication Number Publication Date
AU8011998A AU8011998A (en) 1999-01-04
AU749382B2 true AU749382B2 (en) 2002-06-27

Family

ID=8097044

Family Applications (1)

Application Number Title Priority Date Filing Date
AU80119/98A Ceased AU749382B2 (en) 1997-06-23 1998-06-19 Novel surface exposed proteins from chlamydia pneumoniae

Country Status (13)

Country Link
US (2) US7264941B1 (cg-RX-API-DMAC10.html)
EP (1) EP1007685B1 (cg-RX-API-DMAC10.html)
JP (1) JP4160640B2 (cg-RX-API-DMAC10.html)
CN (1) CN1249233C (cg-RX-API-DMAC10.html)
AT (1) ATE323164T1 (cg-RX-API-DMAC10.html)
AU (1) AU749382B2 (cg-RX-API-DMAC10.html)
BR (1) BR9810288A (cg-RX-API-DMAC10.html)
CA (1) CA2294651A1 (cg-RX-API-DMAC10.html)
DE (1) DE69834194T2 (cg-RX-API-DMAC10.html)
DK (1) DK1007685T3 (cg-RX-API-DMAC10.html)
ES (1) ES2264810T3 (cg-RX-API-DMAC10.html)
PT (1) PT1007685E (cg-RX-API-DMAC10.html)
WO (1) WO1998058953A2 (cg-RX-API-DMAC10.html)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6710033B1 (en) 1996-08-14 2004-03-23 Vanderbilt University Methods and treatment of multiple sclerosis
US6890526B2 (en) 1997-05-06 2005-05-10 Vanderbilt University Methods and reagents for the treatment of multiple sclerosis
US6649370B1 (en) * 1998-10-28 2003-11-18 Aventis Pasteur Limited Chlamydia antigens and corresponding DNA fragments and uses thereof
EP1129202A2 (en) * 1998-10-28 2001-09-05 Aventis Pasteur Limited Chlamydia antigenes and corresponding dna fragments and uses thereof
US6872814B2 (en) * 1998-10-29 2005-03-29 Aventis Pasteur Limited Chlamydia antigens and corresponding DNA fragments and uses thereof
NZ512308A (en) * 1998-12-01 2004-01-30 Aventis Pasteur Chlamydia antigens and corresponding DNA fragments and uses thereof
AU3790900A (en) 1998-12-01 2000-06-19 Aventis Pasteur Limited Chlamydia antigens and corresponding DNA fragments and uses thereof
EP2172214A3 (en) 1999-03-12 2011-03-16 Aventis Pasteur Limited Chlamydia antigens and corresponding DNA fragments and uses thereof
WO2000066739A2 (en) * 1999-05-03 2000-11-09 Aventis Pasteur Limited Chlamydia antigens and corresponding dna fragments and uses thereof
CA2385325C (en) * 1999-09-20 2012-04-10 Aventis Pasteur Limited Chlamydia antigens and corresponding dna fragments and uses thereof
US20010048927A1 (en) 2000-02-01 2001-12-06 Richard Stephens Porin B (PorB) as a therapeutic target for prevention and treatment of infection by chlamydia
ATE440861T1 (de) * 2000-07-03 2009-09-15 Novartis Vaccines & Diagnostic Immunisierung gegen chlamydia pneumoniae
US7105171B2 (en) 2002-03-07 2006-09-12 The Regents Of The University Of California Porin B (PorB) as a therapeutic target for prevention and treatment of infection by Chlamydia
EP3452197A4 (en) 2016-05-04 2020-01-22 Children's Hospital & Research Center at Oakland FAST EXTRACTION OF NUCLEIC ACIDS FROM CLINICAL SAMPLES FOR DOWNSTREAM APPLICATIONS
US20220221456A1 (en) * 2019-05-06 2022-07-14 Arocell Ab Respiratory infection detection and classification

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU692889B2 (en) * 1994-08-03 1998-06-18 Hitachi Chemical Company, Ltd. Monoclonal antibodies having a reactivity specific to Chlamydia pneumoniae, method for production of the monoclonal antibodies, such antibody producing cells, method for production of the cells, method for detection and/or measurement of Chlamydia pneumoniae, reagents for the method, method and agents for diagnosis of chlamydia pneumoniae infection
CN100365017C (zh) 1994-09-20 2008-01-30 日立化成工业株式会社 肺炎衣原体抗原多肽
US6248329B1 (en) * 1998-06-01 2001-06-19 Ramaswamy Chandrashekar Parasitic helminth cuticlin nucleic acid molecules and uses thereof

Also Published As

Publication number Publication date
ATE323164T1 (de) 2006-04-15
US20080226679A1 (en) 2008-09-18
JP2002510970A (ja) 2002-04-09
EP1007685A2 (en) 2000-06-14
ES2264810T3 (es) 2007-01-16
WO1998058953A2 (en) 1998-12-30
PT1007685E (pt) 2006-08-31
AU8011998A (en) 1999-01-04
DK1007685T3 (da) 2006-08-14
WO1998058953A3 (en) 1999-03-18
US7264941B1 (en) 2007-09-04
DE69834194D1 (de) 2006-05-24
CN1249233C (zh) 2006-04-05
DE69834194T2 (de) 2007-03-29
BR9810288A (pt) 2000-09-19
CN1261403A (zh) 2000-07-26
EP1007685B1 (en) 2006-04-12
JP4160640B2 (ja) 2008-10-01
CA2294651A1 (en) 1998-12-30

Similar Documents

Publication Publication Date Title
US20080226679A1 (en) Novel surface exposed proteins from chlamydia pneumoniae
US6264954B1 (en) Haemophilus outer membrane protein
US7846451B2 (en) Moraxella catarrhalis protein, nucleic acid sequence and uses thereof
EP0629132B1 (en) Purified vacuolating toxin from helicobacter pylori and methods to use same
JPH11507214A (ja) Hsp70ファミリーに属する連鎖球菌の熱ショック蛋白質メンバー
JP2001518489A5 (cg-RX-API-DMAC10.html)
JP4707234B2 (ja) シュードモナスv抗原を用いる免疫化のための組成物
JP2001515467A (ja) モラクセラ・カタラーリスのuspa1及びuspa2抗原
CN1326997C (zh) 编码鸭瘟立默氏菌外膜蛋白的OmpA基因及应用方法
JP4368944B2 (ja) 防御用ヘリコバクター抗原
Helbig et al. Monoclonal antibodies to Legionella Mip proteins recognize genus-and species-specific epitopes
CA2719041C (en) A method for identifying polypeptides which comprise a cross-reactive antigenic determinant
EP1029054B1 (en) Hp90: host membrane receptor for pathogenic bacteria, encoded by the bacterial tir gene
CN110691787A (zh) 针对家禽坏死性肠炎的疫苗
AU740481B2 (en) Defining epitopes of the outer membrane protein CopB of moraxella catarrhalis
US7208574B1 (en) Host receptor for pathogenic bacteria
WO1997003360A1 (en) HELICOBACTER VACCINE ANTIGEN RECOGNIZED BY A PROTECTIVE MONOCLONAL ANTIBODY (IgG 50)
EP0915977A1 (en) B. burgdorferi polypeptides expressed in vivo
US20050136422A1 (en) Neisseria spp. polypeptide, nucleic acid sequence and uses thereof

Legal Events

Date Code Title Description
PC1 Assignment before grant (sect. 113)

Owner name: LOKE DIAGNOSTICS APS

Free format text: THE FORMER OWNER WAS: SVEND BIRKELUND, GUNNA CHRISTIANSEN

TH Corrigenda

Free format text: IN VOL 14, NO 13, PAGE(S) 2274 UNDER THE HEADING ASSIGNMENTS BEFORE GRANT, SECTION 113 THE NAME OF THE ASSIGNEE IN REGARD TO PATENT APPLICATION NO. 80119/98 SHOULD READ LOKE DIAGNOSTICS APS.

FGA Letters patent sealed or granted (standard patent)